Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Anderson

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Heart Rhythm|February 22, 2023
Polygenic risk scores are associated with atrial electrophysiologic substrate abnormalities and outcomes after atrial fibrillation catheter ablationAhmed Al-Kaisey, Geoffrey R Wong, Paul Young, et al.
The American Journal of Psychiatry|September 17, 2008
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) studyLinmarie Sikich, Jean A Frazier, Jon McClellan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2022
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challengeRon L H Handels, Colin Green, Anders Gustavsson, et al.
Vaccine|March 15, 2022
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 proteinHong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2024
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's DiseaseRon Handels, William L Herring, Farzam Kamgar, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 2, 2007
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristicsJean A Frazier, Jon McCLELLAN, Robert L Findling, et al.
CJC Open|February 5, 2024
Utilization of Shock Team and Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) in the Management of Cardiogenic Shock in Northern OntarioSami Alnasser, Matthew Cavanagh, Rony Atoui, et al.
JAMA Network Open|November 19, 2020
Delirium in Older Patients With COVID-19 Presenting to the Emergency DepartmentMaura Kennedy, Benjamin K I Helfand, Ray Yun Gou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2017
Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue InfectionShu-Wen Wan, Pei-Wei Chen, Chin-Yu Chen, et al.
Plos Pathogens|April 29, 2022
Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse modelSen-Mao Tien, Po-Chun Chang, Yen-Chung Lai, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Heart Rhythm|February 22, 2023
Polygenic risk scores are associated with atrial electrophysiologic substrate abnormalities and outcomes after atrial fibrillation catheter ablationAhmed Al-Kaisey, Geoffrey R Wong, Paul Young, et al.
The American Journal of Psychiatry|September 17, 2008
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) studyLinmarie Sikich, Jean A Frazier, Jon McClellan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2022
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challengeRon L H Handels, Colin Green, Anders Gustavsson, et al.
Vaccine|March 15, 2022
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 proteinHong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2024
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's DiseaseRon Handels, William L Herring, Farzam Kamgar, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 2, 2007
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristicsJean A Frazier, Jon McCLELLAN, Robert L Findling, et al.
CJC Open|February 5, 2024
Utilization of Shock Team and Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) in the Management of Cardiogenic Shock in Northern OntarioSami Alnasser, Matthew Cavanagh, Rony Atoui, et al.
JAMA Network Open|November 19, 2020
Delirium in Older Patients With COVID-19 Presenting to the Emergency DepartmentMaura Kennedy, Benjamin K I Helfand, Ray Yun Gou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2017
Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue InfectionShu-Wen Wan, Pei-Wei Chen, Chin-Yu Chen, et al.
Plos Pathogens|April 29, 2022
Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse modelSen-Mao Tien, Po-Chun Chang, Yen-Chung Lai, et al.
Pageof 22